RT Journal Article
SR Electronic
T1 Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002757
DO 10.1136/jitc-2021-002757
VO 9
IS 8
A1 Rischin, Danny
A1 Khushalani, Nikhil I
A1 Schmults, Chrysalyne D
A1 Guminski, Alexander
A1 Chang, Anne Lynn S
A1 Lewis, Karl D
A1 Lim, Annette M
A1 Hernandez-Aya, Leonel
A1 Hughes, Brett G M
A1 Schadendorf, Dirk
A1 Hauschild, Axel
A1 Thai, Alesha A
A1 Stankevich, Elizabeth
A1 Booth, Jocelyn
A1 Yoo, Suk-Young
A1 Li, Siyu
A1 Chen, Zhen
A1 Okoye, Emmanuel
A1 Chen, Chieh-I
A1 Mastey, Vera
A1 Sasane, Medha
A1 Lowy, Israel
A1 Fury, Matthew G
A1 Migden, Michael R
YR 2021
UL http://jitc.bmj.com/content/9/8/e002757.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.